SynDRA canonical compound SYN0002416 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|---|
| Primary target(s) | ALB | LTB4R | NOX3 |
| Mechanism of action | cyclooxygenase inhibitor | glutathione peroxidase agonist | H+/K+-ATPase inhibitor | nitric oxide synthase inhibitor |